Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors
- PMID: 11795995
- DOI: 10.1053/joca.2001.0472
Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors
Abstract
Objective: To determine the effect of matrix metalloproteinase (MMP) inhibitors in mono-iodoacetate-induced arthritis in rats.
Design: The ability of compounds to inhibit MMPs in vitro was assessed kinetically using a quenched fluorescent substrate. Rats were injected with iodoacetate intraarticularly in one knee joint and damage to the tibial plateau was evaluated from digitized images captured using an image analyser and by histology. Collagenase and gelatinase activity in cartilage from iodoacetate injected knees were evaluated using(3)H-rat type I collagen and gelatin zymography, respectively.
Results: Collagenase and gelatinase activity significantly increased in the knee cartilage of rats injected with iodoacetate with peak activity by day 7. Three MMP inhibitors were examined for their efficacy in the rat iodoacetate-induced arthritis model. Significant (P< 0.05) inhibition of cartilage damage was observed in animals treated orally with 35 mg/kg b.i.d. of the three different MMP inhibitors. Inhibition of cartilage damage by the MMP inhibitors ranged from 36-42%.
Conclusion: MMP inhibitors are partially protective against cartilage and subchondral bone damage induced by iodoacetate. These results support an important role for MMPs in mediating the joint damage in this model of arthritis.
Copyright 2001 OsteoArthritis Research Society International.
Similar articles
-
Detection of aggrecanase- and MMP-generated catabolic neoepitopes in the rat iodoacetate model of cartilage degeneration.Osteoarthritis Cartilage. 2004 Sep;12(9):720-8. doi: 10.1016/j.joca.2004.06.004. Osteoarthritis Cartilage. 2004. PMID: 15325638
-
A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.Arthritis Rheum. 2009 Jul;60(7):2008-18. doi: 10.1002/art.24629. Arthritis Rheum. 2009. PMID: 19565489
-
Comparison of the pharmacology of hydroxamate- and carboxylate-based matrix metalloproteinase inhibitors (MMPIs) for the treatment of osteoarthritis.Inflamm Res. 2006 Feb;55(2):60-5. doi: 10.1007/s00011-005-0014-4. Inflamm Res. 2006. PMID: 16612565
-
Matrix metalloproteinase inhibitors in rheumatic diseases.Ann Rheum Dis. 2001 Nov;60 Suppl 3(Suppl 3):iii62-7. doi: 10.1136/ard.60.90003.iii62. Ann Rheum Dis. 2001. PMID: 11890658 Free PMC article. Review.
-
Advances in studies on collagenase inhibitors.Exp Suppl. 2012;103:83-135. doi: 10.1007/978-3-0348-0364-9_4. Exp Suppl. 2012. PMID: 22642191 Review.
Cited by
-
Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis.Mol Biol Rep. 2012 May;39(5):5683-9. doi: 10.1007/s11033-011-1376-z. Epub 2011 Dec 20. Mol Biol Rep. 2012. PMID: 22183306 Review.
-
Intra-Articular Hyaluronic Acid and Chondroitin Sulfate: Pharmacokinetic Investigation in Osteoarthritic Rat Models.Curr Ther Res Clin Exp. 2019 Dec 9;92:100573. doi: 10.1016/j.curtheres.2019.100573. eCollection 2020. Curr Ther Res Clin Exp. 2019. PMID: 31956378 Free PMC article.
-
Chitosan and Lecithin Ameliorate Osteoarthritis Symptoms Induced by Monoiodoacetate in a Rat Model.Molecules. 2020 Dec 4;25(23):5738. doi: 10.3390/molecules25235738. Molecules. 2020. PMID: 33291821 Free PMC article.
-
Therapeutic Nanodiamonds Containing Icariin Ameliorate the Progression of Osteoarthritis in Rats.Int J Mol Sci. 2023 Nov 5;24(21):15977. doi: 10.3390/ijms242115977. Int J Mol Sci. 2023. PMID: 37958960 Free PMC article.
-
Involvement of Nav 1.8 sodium ion channels in the transduction of mechanical pain in a rodent model of osteoarthritis.Arthritis Res Ther. 2012 Jan 7;14(1):R5. doi: 10.1186/ar3553. Arthritis Res Ther. 2012. PMID: 22225591 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical